Biomedical Engineering Research Centre, Division of Biomedical Engineering, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa.
Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
BMC Neurosci. 2023 Feb 24;24(1):15. doi: 10.1186/s12868-023-00783-7.
Life-long early ART (started before age 2 years), often with periods of treatment interruption, is now the standard of care in pediatric HIV infection. Although cross-sectional studies have investigated HIV-related differences in cortical morphology in the setting of early ART and ART interruption, the long-term impact on cortical developmental trajectories is unclear. This study compares the longitudinal trajectories of cortical thickness and folding (gyrification) from age 5 to 9 years in a subset of children perinatally infected with HIV (CPHIV) from the Children with HIV Early antiRetroviral therapy (CHER) trial to age-matched children without HIV infection.
75 CHER participants in follow-up care at FAMCRU (Family Centre for Research with Ubuntu), as well as 66 age-matched controls, received magnetic resonance imaging (MRI) on a 3 T Siemens Allegra at ages 5, 7 and/or 9 years. MR images were processed, and cortical surfaces reconstructed using the FreeSurfer longitudinal processing stream. Vertex-wise linear mixed effects (LME) analyses were performed across the whole brain to compare the means and linear rates of change of cortical thickness and gyrification from 5 to 9 years between CPHIV and controls, as well as to examine effects of ART interruption.
Children without HIV demonstrated generalized cortical thinning from 5 to 9 years, with the rate of thinning varying by region, as well as regional age-related gyrification increases. Overall, the means and developmental trajectories of cortical thickness and gyrification were similar in CPHIV. However, at an uncorrected p < 0.005, 6 regions were identified where the cortex of CPHIV was thicker than in uninfected children, namely bilateral insula, left supramarginal, lateral orbitofrontal and superior temporal, and right medial superior frontal regions. Planned ART interruption did not affect development of cortical morphometry.
Although our results suggest that normal development of cortical morphometry between the ages of 5 and 9 years is preserved in CPHIV who started ART early, these findings require further confirmation with longitudinal follow-up through the vulnerable adolescent period.
终身早期抗逆转录病毒治疗(在 2 岁之前开始),通常伴有治疗中断期,目前是儿科人类免疫缺陷病毒(HIV)感染的标准治疗方法。尽管横断面研究已经调查了在早期抗逆转录病毒治疗和抗逆转录病毒治疗中断的背景下,与 HIV 相关的皮质形态差异,但皮质发育轨迹的长期影响尚不清楚。本研究比较了儿童期 HIV 早期抗逆转录病毒治疗(CHER)试验中一组经围生期感染 HIV 的儿童(CPHIV)与年龄匹配的无 HIV 感染儿童从 5 岁到 9 岁皮质厚度和折叠(脑回形成)的纵向轨迹。
在家庭研究与乌班图中心(FAMCRU)接受随访护理的 75 名 CHER 参与者,以及 66 名年龄匹配的对照者,在 5 岁、7 岁和/或 9 岁时在 3T 西门子 Allegra 上接受磁共振成像(MRI)检查。使用 FreeSurfer 纵向处理流对 MRI 进行处理,并重建皮质表面。在整个大脑中进行顶点线性混合效应(LME)分析,以比较 CPHIV 和对照组从 5 岁到 9 岁皮质厚度和脑回形成的平均值和线性变化率,并检查抗逆转录病毒治疗中断的影响。
无 HIV 的儿童从 5 岁到 9 岁表现出广泛的皮质变薄,变薄的速度因区域而异,以及区域与年龄相关的脑回形成增加。总体而言,CPHIV 的皮质厚度和脑回形成的平均值和发育轨迹相似。然而,在未校正的 p<0.005 时,有 6 个区域的 CPHIV 皮质比未感染儿童厚,即双侧岛叶、左侧缘上回、外侧眶额和颞上回,以及右侧内侧额上回。计划的抗逆转录病毒治疗中断并没有影响皮质形态测量的发育。
尽管我们的研究结果表明,在早期开始抗逆转录病毒治疗的 CPHIV 中,5 至 9 岁之间皮质形态的正常发育得到保留,但这些发现需要通过脆弱的青少年期进行纵向随访进一步证实。